RESOURCES | Cannabis Security | Cannabis Securities News

Cannabis-Linked Securities Update | Week of November 1, 2021
Published on November 9, 2021

CRB Monitor Securities Database Updates

During the week of Monday November 1, 2021, CRB Monitor’s research team made several updates to securities’ information and added source documents & relevant news articles to the CRB Monitor database. Here is a summary of the updates for the Week of Monday November 1, 2021:

Tier

Total #

Active / Inactive

Added

Removed

Net Change

Tier 1A

105

87 / 18

+2

-1

+1

Tier 1B

683

577 / 106

+0

-1

-1

Tier 2

346

320 / 26

+0

-0

+0

Tier 3

541

522 / 19

+0

-0

+0

Total Issuances

1,675

1,506 / 169

+2

-2

+0

Total Issuers

1,384

-

+1

-2

-1

 

  • Added 2 Tier 1A Securities & Removed 1 Tier 1A Security:
    • +1 = New CRB (“Cannomed Medical Cannabis Industries Ltd”) – Common Security
    • +1 = New CRB (“Cannomed Medical Cannabis Industries Ltd”) – Warrant Security
    • -1 = Move to Watchlist: “Cellect Biotechnology Ltd.” (Rationale = Completed merger & subsequently changed name to Quoin Pharmaceuticals, Ltd. (Nasdaq: QNRX). As a result, no longer has any connection to the cannabis industry.)
  • Removed 1 Tier 1B Security:
    • -1 = Move to Watchlist: “Alchemist Mining Incorporated” (Rationale = All agreements to acquire CRBs have been terminated and/or expired. Per its own admission, “Going forward plans to restructure and establish operations within the mining sector.”)

All newly-identified CRBs during the week:

Company Name

Tier

Sector

Description

 

Cannomed Medical Cannabis Industries Ltd

(TASE: CNMD)

1A Licensed CRB

Cannomed is an Israel-based rising leader in the medical cannabis industry with its unique manufacturing plant which grows and processes medical cannabis products. Cannomed received all permits and licenses required to grow and produce medical cannabis from the Israeli Ministry of Health.

 

 

Most Popular

Subscribe For Updates

Explore how CRBMonitor can simplify your cannabis-related compliance challenges.